Epigenetic inactivation of INK4/CDK/RB cell cycle pathway in acute leukemias

Annals of Hematology

Volumn 82, Issue 12, 2003, Pages 738-742

  Chim, C S ^a   Wong, A S Y ^a   Kwong, Y L ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

Acute leukemias; CKI; INK4; MSP

Indexed keywords

CYCLIN DEPENDENT KINASE; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; PROTEIN P15; PROTEIN P16; PROTEIN P18; PROTEIN P19; RETINOBLASTOMA PROTEIN; TIOGUANINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER CLASSIFICATION; CANCER REGRESSION; CANCER SURVIVAL; CARCINOGENESIS; CELL CYCLE; CELL STRAIN U937; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EPIGENETICS; FEMALE; GENE DELETION; GENE INACTIVATION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LEUKEMOGENESIS; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; PROTEIN METHYLATION; RAJI CELL;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CELL CYCLE; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR PROTEINS; CYCLIN-DEPENDENT KINASES; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; PROGNOSIS; RETINOBLASTOMA PROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; U937 CELLS;

EID: 0348149013     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-003-0744-8     Document Type: Article

References (42)

1. Hann WC, Weinberg RA (2002) Rules for making human tumor cells. N Engl J Med 347:1593-1603
2. Malumbres M, Barbacid M (2001) To cycle or not to cycle: a critical decision in cancer. Nat Cancer Rev 1:222-231
3. Hirama T, Koeffler HP (1995) Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood 86:841-854
4. Sherr CJ (1994) Cancer cell cycle. Science 274:1672-1677
5. Roussel MF (1999) The INK4 family of cell cycle inhibitors in cancer. Oncogene 18:5311-5317
6. Jeffrey PD, Tong L, Pavletich NP (2000) Structural basis of inhibition of CDK-cyclin complexes by INK4 inhibitors. Genes Dev 14:3115-3125
7. Sherr CJ, Roberts JM (1999) CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13:1501-1512
8. Baylin SB, Herman JG, Graff JR, VertinoPM, Issa JP (1998) Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 72:141-196
9. Robertson KD, Wolffe AP (2000) DNA methylation in health and disease. Nat Rev 1:11-19
10. Singal R, Ginder GD (1999) DNA methylation. Blood 93:4059-4070
11. Chim CS, Liang R, Kwong YL (2002) Gene promoter hypermethylation in hematologic malignancies. Hematol Oncol 20:167-176
12. Siegfried Z, Eden S, Mendelsohn M, Feng X, Tsuberi BZ, Cedar H (1999) DNA methylation represses transcription in vivo. Nat Genet 22:203-206
13. Jones PA, Laird PW (1999) Cancer epigenetics comes of age. Nat Genet 21:163-167
14. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, et al. (1976) Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol 33:451-458
15. Second MIC Cooperative Study Group (1988) Morphologic, immunologic and cytogenetic (MIC) working classification of the acute myeloid leukaemias. Br J Haematol 68:487-494
16. Chim, CS, Tam C, Liang R, Kwong YL (2001) P15 and P16 gene methylation in adult acute leukemia: lack of prognostic significance. Cancer 91:2222-2229
17. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB (1996) Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 93:9821-9826
18. Chim CS, Liang R, Tam C, Kwong YL (2001) P15 and P16 promoter methylation in acute promyelocytic leukemia. J Clin Oncol 19:2033-2040
19. Roncalli M, Bianchi P, Bruni B, Laghi L, Destro A, Di Gioia S, Gennari L, Tommasini M, Malesci A, Coggi G (2002) Methylation framework of cell cycle gene inhibitors in cirrhosis and associated hepatocellular carcinoma. Hepatology 36:427-432
20. Simpson DJ, Hibberts NA, McNicol AM, Clayton RN, Farrell WE (2000) Loss of pRb expression in pituitary adenomas is associated with methylation of the RB1 CpG island. Cancer Res 60:1211-1216
21. Zindy F, van Deursen J, Grosveld G, Sherr CJ, Roussel MF (2000) INK4d-deficient mice are fertile despite testicular atrophy. Mol Cell Biol 20:372-378
22. Pabst T, Mueller BU, Zhang P, Radomska HS, Narravula S, Schnittger S, Behre G, Hiddemann W, Tenen DG (2001) Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia. Nat Genet 27:263-270
23. Chim CS, Wong AS, Kwong YL (2002) Infrequent hypermethylation of CEBPA promotor in acute myeloid leukaemia. Br J Haematol 119:988-990
24. Preisler HD, Li B, Chen H, Fisher L, Nayini J, Raza A, Creech S, Venugopal P (2001) P151NK4B gene methylation and expression in normal, myelodysplastic, and acute myelogenous leukemia cells and in the marrow cells of cured lymphoma patients. Leukemia 15:1589-1595
25. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA (1994) Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368:753-756
26. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS, Johnson BE, Skolnick MH (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science 264:436-440
27. Drexler HG (1998) Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells. Leukemia 12:845-859
28. Ng MH, Chung YF, Lo KW, Wickham NW, Lee JC, Huang DP (1997) Frequent hypermethylation of p16 and p15 genes in multiple myeloma. Blood 89:2500-2506
29. Sauerbrey A, Stammler G, Zintl F, Volm M (1998) Expression of the retinoblastoma tumor suppressor gene (RB-1) in acute leukemia. Leuk Lymphoma 28:275-283
30. Jamal R, Gale RE, Shaun N, Thomas B, Wheatley K, Linch DC (1996) The retinoblastoma gene (rb1) in acute myeloid leukaemia: analysis of gene rearrangements, protein expression and comparison of disease outcome. Br J Haematol 94:342-351
31. Hangaishi A, Ogawa S, Imamura N, Miyawaki S, Miura Y, Uike N, Shimazaki C, Emi N, Takeyama K, Hirosawa S, Kamada N, Kobayashi Y, Takemoto Y, Kitani T, Toyama K, Ohtake S, Yazaki Y, Ueda R, Hirai H (1996) Inactivation of multiple tumor-suppressor genes involved in negative regulation of the cell cycle, MTS1/p16INK4A/CDKN2, MTS2/p15INK4B, p53, and Rb genes in primary lymphoid malignancies. Blood 87:4949-4958
32. Barbosa de Melo M, Costa FF, Saad ST, Lorand-Metze I, Bordin S, Ahmad NN (1998) Molecular analysis of the retinoblastoma (RB1) gene in acute myeloid leukemia patients. Leuk Res 22:787-792
33. Guan KL, Jenkins CW, Li Y, Nichols MA, Wu X, O'Keefe CL, Matera AG, Xiong Y (1994) Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev 8:2939-2952
34. Franklin DS, Godfrey VL, Lee H, Kovalev GI, Schoonhoven R, Chen-Kiang S, Su L, Xiong Y (1998) CDK inhibitors p18(INK4c) and p27(Kip1) mediate two separate pathways to collaboratively suppress pituitary tumorigenesis. Genes Dev 12:2899-2911
35. Latres E, Malumbres M, Sotillo R, Martin J, Ortega S, Martin-Caballero J, Flores JM, Cordon-Cardo C, Barbacid M (2000) Limited overlapping roles of P15(INK4b) and P18(INK4c) cell cycle inhibitors in proliferation and tumorigenesis. EMBO J 19:3496-3506
36. Takeuchi S, Bartram CR, Seriu T, Miller CW, Tobler A, Janssen JW, Reiter A, Ludwig WD, Zimmermann M, Schwaller J, et al. (1995) Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/INK4B, p16/MTS1/INK4A, and p18 genes in acute lymphoblastic leukemia of childhood. Blood 86:755-760
37. Nakamaki T, Kawamata N, Schwaller J, Tobler A, Fey M, Pakkala S, Lee YY, Kim BK, Fukuchi K, Tsuruoka N, et al. (1995) Structural integrity of the cyclin-dependent kinase inhibitor genes, p15, p16 and p18 in myeloid leukaemias. Br J Haematol 91:139-149
38. Maesawa C, Tamura G, Nishizuka S, et al. (1996) Inactivation of the CDKN2 gene by homozygous deletion and de novo methylation is associated with advanced stage esophageal squamous cell carcinoma. Cancer Res 56:3875-3878
39. Tang X, Khuri FR, Lee JJ, Kemp BL, Liu D, Hong WK, Mao L (2000) Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer. J Natl Cancer Inst 92:1511-1516
40. Esteller M, Gaidano G, Goodman SN, Zagonel V, Capello D, Botto B, Rossi D, Gloghini A, Vitolo U, Carbone A, Baylin SB, Herman JG (2002) Hypermethylation of the DNA repair gene O(6)-methylguanine DNA methyltransferase and survival of patients with diffuse large B-cell lymphoma. J Natl Cancer Inst 94:26-32
41. Wijermans P, Lubbert M, Verhoef G, et al. (2000) Low-dose 5-aza-2′-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: a multicenter phase II study in elderly patients. J Clin Oncol 18:956-962
42. Silverman LR, Demakos EP, Bercedis L, et al. (2002) A randomized controlled trial of azacitidine in patients with myelodysplastic syndrome: a study of the cancer and leukemia group B. J Clin Oncol 20:2429-2440